Pacifico Biolabs
22 employees on LinkedIn · 4 known investors
Pacifico Biolabs produces mycelium-based meat alternatives (branded Viando), starting with a chicken alternative made from fermented fungi, for food manufacturers and food service chains. It uses steel fermentation bioreactors to make its "mycomeat" as a B2B ingredient that integrates into existing meat supply chains and cooking processes.
Investors · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AMay 2026 · 4 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Pacifico Biolabs do?
- Pacifico Biolabs produces mycelium-based meat alternatives (branded Viando), starting with a chicken alternative made from fermented fungi, for food manufacturers and food service chains. It uses steel fermentation bioreactors to make its "mycomeat" as a B2B ingredient that integrates into existing meat supply chains and cooking processes.
- Who are Pacifico Biolabs's investors?
- Pacifico Biolabs's investors include Exceptional Ventures, FoodLabs, Simon Capital, Stray Dog Capital.